Fidelity Investments
TLX

Fidelity Investments’s Telix Pharmaceuticals TLX Stock Holding History

Fidelity Investments’s Portfolio TLX Stock Details TLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.4M Buy
564,757
+441,187
+357% +$3.36M ﹤0.01% 2278
2025
Q4 		$926K Buy
123,570
+5,091
+4% +$49K ﹤0.01% 2873
2025
Q3 		$1.13M Buy
118,479
+76,388
+181% +$936K ﹤0.01% 2753
2025
Q2 		$681K Buy
+42,091
New +$707K ﹤0.01% 2861

Other funds holding TLX

PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
PIC
Portland Investment Counsel Burlington, Ontario, Canada $312M AUM 53.32% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.3B AUM 22.13% 1-Year Est. Return
IWC
Integrated Wealth Concepts Waltham, Massachusetts $12.5B AUM 18.49% 1-Year Est. Return
RBI
Raiffeisen Bank International Vienna, Austria $6.97B AUM 29.39% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Mariner
Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

Fidelity Investments's TLX Position: Q1 2026 in Review

Fidelity Investments increased its Telix Pharmaceuticals (TLX) stake by 357% in Q1 2026, buying an estimated $3.36M and bringing the position to 564,757 shares worth $5.4M. The position accounts for ﹤0.01% of the portfolio, ranked #2278.

Fidelity Investments first reported a position in TLX in Q2 2025 and has held it in 4 quarters since. 39 funds tracked by Wall St. Rank hold TLX as of Q1 2026.

  • Fidelity Investments held 564,757 shares of Telix Pharmaceuticals worth $5.4M as of Q1 2026.
  • Fidelity Investments bought 441,187 Telix Pharmaceuticals shares in Q1 2026, an estimated $3.36M.
  • Telix Pharmaceuticals made up ﹤0.01% of Fidelity Investments's portfolio in Q1 2026, its #2278 holding.
  • Fidelity Investments first reported a position in Telix Pharmaceuticals in Q2 2025 and has held it in 4 quarters since.
  • 39 funds tracked by Wall St. Rank held Telix Pharmaceuticals as of Q1 2026.

Based on Fidelity Investments's 13F filing for Q1 2026, filed 15 May 2026.